IsoPlexis Profit Margin

The latest profit margin for ISO is -663.5% as of December 2022. That compares with -567.49% in the prior-year period — down 16.9% year over year. That is below the Healthcare sector average of 13.89%. Investors often review this figure alongside IsoPlexis's historical trend and sector peers before judging valuation or financial health.

Over the past year, ISO's profit margin moved from -567.49% to -663.5% — a 16.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in IsoPlexis's valuation or profitability profile.

Against Healthcare companies, ISO currently prints -663.5% for profit margin, while the sector average sits near 13.89%. That is roughly 4878.5% below the sector mean. Large gaps often invite a closer look at IsoPlexis's growth, margins, and balance sheet.

Profit Margin shows how effectively IsoPlexis converts resources into returns. At -663.5%, ISO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -567.49% in the prior-year period — down 16.9% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting ISO's profit margin (-663.5%), review year-over-year change from -567.49%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.